Cargando…

Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma

BACKGROUND: Inattention has been given to the pathogenesis of adolescent and young adult (AYA) hepatocellular carcinoma (HCC). Due to the more advanced tumor progression and poorer prognosis of AYA-HCC, together with a better tolerance ability, noncirrhotic background, and a stronger willingness to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Tao, Zhang, Bo, Xu, Xi, Jiang, Chenhao, Zheng, Daofeng, He, Diao, Zhou, Yongjie, Yang, Jiayin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262462/
https://www.ncbi.nlm.nih.gov/pubmed/37312215
http://dx.doi.org/10.1186/s40246-023-00500-9
_version_ 1785058059599478784
author Lv, Tao
Zhang, Bo
Xu, Xi
Jiang, Chenhao
Zheng, Daofeng
He, Diao
Zhou, Yongjie
Yang, Jiayin
author_facet Lv, Tao
Zhang, Bo
Xu, Xi
Jiang, Chenhao
Zheng, Daofeng
He, Diao
Zhou, Yongjie
Yang, Jiayin
author_sort Lv, Tao
collection PubMed
description BACKGROUND: Inattention has been given to the pathogenesis of adolescent and young adult (AYA) hepatocellular carcinoma (HCC). Due to the more advanced tumor progression and poorer prognosis of AYA-HCC, together with a better tolerance ability, noncirrhotic background, and a stronger willingness to treat AYA-HCC, clinical and molecular biology studies are urgent and necessary, especially for those with hepatitis B infection. METHODS: For clinical aspects, the overall survival, the recurrence-free survival, and the Cox analyses were performed. Then, functional analysis, gene clustering, metabolic-related analysis, immune infiltration and competing endogenous RNA (ceRNA) construction were carried out using whole transcriptome sequencing technique. RESULTS: Based on the clinical information of our HCC cohort, the overall survival and recurrence-free survival rates were worse in the AYA group than in the elderly group as previously described. According to our whole transcriptome sequencing results, functional analysis revealed that metabolism-related pathways as well as protein translation and endoplasmic reticulum processing were enriched. Then the hub metabolism-related genes were screened by metabolite–protein interactions (MPIs) and protein–protein interactions (PPIs). Fatty acid metabolism is a crucial component of metabolic pathways, abnormalities of which may be the reason for the worse prognosis of HBV-AYA HCC. Finally, the relationship of disrupted expression of metabolism-related genes with immune infiltration was also analyzed, and the lncRNA‒miRNA‒mRNA-related ceRNA network for HBV-AYA HCC was constructed, which may provide new cues for HBV-AHA HCC prevention. CONCLUSION: The worse prognosis and recurrence rate of HBV-AYA HCC may be related to abnormalities in metabolism-related pathways, especially disorders of fatty acid metabolism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-023-00500-9.
format Online
Article
Text
id pubmed-10262462
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102624622023-06-15 Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma Lv, Tao Zhang, Bo Xu, Xi Jiang, Chenhao Zheng, Daofeng He, Diao Zhou, Yongjie Yang, Jiayin Hum Genomics Research BACKGROUND: Inattention has been given to the pathogenesis of adolescent and young adult (AYA) hepatocellular carcinoma (HCC). Due to the more advanced tumor progression and poorer prognosis of AYA-HCC, together with a better tolerance ability, noncirrhotic background, and a stronger willingness to treat AYA-HCC, clinical and molecular biology studies are urgent and necessary, especially for those with hepatitis B infection. METHODS: For clinical aspects, the overall survival, the recurrence-free survival, and the Cox analyses were performed. Then, functional analysis, gene clustering, metabolic-related analysis, immune infiltration and competing endogenous RNA (ceRNA) construction were carried out using whole transcriptome sequencing technique. RESULTS: Based on the clinical information of our HCC cohort, the overall survival and recurrence-free survival rates were worse in the AYA group than in the elderly group as previously described. According to our whole transcriptome sequencing results, functional analysis revealed that metabolism-related pathways as well as protein translation and endoplasmic reticulum processing were enriched. Then the hub metabolism-related genes were screened by metabolite–protein interactions (MPIs) and protein–protein interactions (PPIs). Fatty acid metabolism is a crucial component of metabolic pathways, abnormalities of which may be the reason for the worse prognosis of HBV-AYA HCC. Finally, the relationship of disrupted expression of metabolism-related genes with immune infiltration was also analyzed, and the lncRNA‒miRNA‒mRNA-related ceRNA network for HBV-AYA HCC was constructed, which may provide new cues for HBV-AHA HCC prevention. CONCLUSION: The worse prognosis and recurrence rate of HBV-AYA HCC may be related to abnormalities in metabolism-related pathways, especially disorders of fatty acid metabolism. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40246-023-00500-9. BioMed Central 2023-06-13 /pmc/articles/PMC10262462/ /pubmed/37312215 http://dx.doi.org/10.1186/s40246-023-00500-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lv, Tao
Zhang, Bo
Xu, Xi
Jiang, Chenhao
Zheng, Daofeng
He, Diao
Zhou, Yongjie
Yang, Jiayin
Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title_full Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title_fullStr Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title_full_unstemmed Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title_short Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
title_sort clinical prognosis and related molecular features of hepatitis b-associated adolescent and young adult hepatocellular carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262462/
https://www.ncbi.nlm.nih.gov/pubmed/37312215
http://dx.doi.org/10.1186/s40246-023-00500-9
work_keys_str_mv AT lvtao clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT zhangbo clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT xuxi clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT jiangchenhao clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT zhengdaofeng clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT hediao clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT zhouyongjie clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma
AT yangjiayin clinicalprognosisandrelatedmolecularfeaturesofhepatitisbassociatedadolescentandyoungadulthepatocellularcarcinoma